𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pancreatoblastoma: Response to chemotherapy

✍ Scribed by Vannier, Jean-Pierre ;Flamant, Françoise ;Hemet, Jacques ;Caillaud, Jean Michel ;Gruner, Max ;Bachy, Bruno ;Lefur, René ;Lemerle, Jean ;Tron, Philippe


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
548 KB
Volume
19
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Two cases of pancreatoblastoma in children are reported here. Only biopsies were made at laparotomy as surgical resection by duodeno-pancreatectomy was not possible. In both children a dramatic response was observed with chemotherapy: doxorubicin plus cisplatin for one, cyclophosphamide, actinomycin D, bleomycin, vinblastine sulfate, and cisplatin for the other. After completion of the chemotherapy the first patient had a local resection; then he had radiotherapy. He is alive in first remission 40 months after the end of the treatment. In the second patient, regional recurrence occurred 8 months after chemotherapy was ended. A transient second remission was obtained with ifosfamide plus etoposide alternating with epirubicin plus vincristine. The patient died 36 months after the diagnosis. Therefore, these two cases suggest that chemotherapy may be proposed before any attempt at surgical excision. Nevertheless, early consolidation by radical resection or irradiation must be considered.


📜 SIMILAR VOLUMES


Osteoblastoma response to chemotherapy
✍ Bruce Camitta; Robert Wells; Annette Segura; K. Krishnan Unni; Kevin Murray; Dav 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB
Osteoblastoma response to radiotherapy a
✍ Berberoglu, Semha; Oguz, Aynur; Aribal, Erkin; Ataoglu, Ömür 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Osteoblastoma is a rare primary bone tumor that is curable by complete excision. There are few data about the effectiveness of chemotherapy or radiotherapy in the treatment of recurrent osteoblastoma. We report a 13-year-old girl wit recurrent osteoblastoma who, after in complete surgical excision,